As optimism for GLP-1 receptor agonists for weight loss has grown, so too has their use in children. Currently, liraglutide ...

GLP-1 drug shortages, driven by cosmetic and weight loss purposes, result in access disparities among individuals with ...

The FDA warns GLP-1 weight loss drug users of aspiration risks during anaesthesia Learn what this update means and how to stay safe before surgeries ...

Medically reviewed by Danielle Weiss, MD After losing extra pounds on Ozempic (semaglutide), some are finding themselves ...

As the FDA issues a new warning about aspiration across all GLP-1 weight loss drugs, doctor groups are giving new ...

A registered dietitian reveals nine food that work like weight-loss drugs, helping to curb cravings and suppress your ...

Scientists from the University of Copenhagen say they have developed a drug that decreases appetite while increasing calorie ...

Poorer folks' access to blockbuster weight-loss drugs through Medicaid ... treatment of obesity using glucagon-like peptide-1 agonist (GLP-1) medications, researchers discovered.

The FDA is warning that patients taking GLP-1s may be at a higher risk of inhaling fluid into their lungs while under ...

In addition to ensuring equitable access to the glucagon-like peptide-1 (GLP-1 ... interest in these medications—initially ...

SAN ANTONIO -- Research presented at the ObesityWeek annual meeting included studies on rationing of prescription medications ...

The weight-loss drug Ozempic can help reduce stroke patients' risk of a heart attack or death, a new study says.